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A B S T R A C T
Ouratea and the other genera of the Ochnaceae family are a rich source of flavonoids and 
biflavonoids. These can be used as chemotaxonomic markers of Ouratea. Some biflavonoids, 
as well as extracts of the Ouratea species show important biological activities, such as anti-
tumour, antiviral, vasodilation, antimicrobial and DNA topoisomerase inhibition. On the 
other hand species of this genus are used in folk medicine for gastric distress, dysentery, and 
diarrhea; as an astringent, a tonic, and for the treatment of inflammation-related diseases. 
The information collected in this review attempts to summarise the phytochemical and 
biological activities studied in Ouratea species that may be helpful to guide researches, to 
undertake further investigation concerning the common properties of Ouratea species and 
evaluation as a source of active compounds.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved. 
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Introduction
The Ochnaceae family comprises 27 genera and 600 tropical 
species distributed in tropical and subtropical zones 
throughout the world (Amaral, 1991). Ouratea is the largest 
genus of this family and comprises approximately 300 tropical 
species appearing mainly in South America and tropical Africa 
(Heywood, 1978; Dahlgren, 1980). Among these species, 120 are 
endemic to the  Neotropical zone (Sastre, 1988; Salvador et al., 
2010) along 28 species recently described (Sastre, 1995; 1997; 
2001; 2004; 2005; 2006; 2007; Yamamoto, 1995; Salvador et al., 
2006). The species are evergreen trees, shrubs, and shrublets 
(Chacon, 2011; Carvalho et al., 2000).
The Ochnaceae family has been characterized as a 
major source of biflavonoids and up to now it has been 
best represented by the Lophira (Ghogomu et al., 1989; 1990; 
Tih et al., 1999; 2006), Luxemburgia (Oliveira et al., 2002; Carvalho 
et al., 2004), Ochna (Anuradha et al., 2006; Bandi et al., 2012) 
and Ouratea (Velandia et al., 2002; Fidelis et al., 2012) genera.
The biflavonoids of the Ouratea genus are found as flavone-
chalcone dimers, and rarely biisoflavone, and can be used as 
chemotaxonomic markers of genus. Besides the flavonoids 
and biflavonoids, several metabolites have been isolated from 
this genus such as lignans, triterpenes, diterpenes, steroids, 
monosaccharides, depsides, and triacylglicerides (Suzart et 
al., 2007a). Ouratea species are used in folk medicine to treat 
gastric distress, dysentery, and diarrhoea (Mbing et al., 2006); 
as an astringent, and tonic (Estevam et al., 2005), as well as 
for the treatment of inflammation-related diseases such as 
rheumatism, sprains and arthritic disorders (Carbonari et al., 
2006). Furthermore, scientific studies have revealed important 
biological activities of biflavonoids and extracts of Ouratea, 
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such as anti-tumour, antiviral and antimicrobial activities 
among other pharmacological activities (Suzart et al., 2007a), 
but not all have a popular use. Hence, Ouratea species have 
been investigated biologically, but some ethnopharmacological 
effects remain undetermined.
In this review, all isolated constituents will be analysed 
based on their biological activities, however the traditional 
uses will be considered.www
Ethnopharmacology
Some members of the Ouratea genus have been used in 
traditional medicine in Brazil and many African countries, 
including Cameroon, Nigeria, Congo and Gabon (Bouquet, 
1969). The leaves and stem are the most commonly used parts 
of the plant, mainly as the juice form, and as infusions and 
extracts. In Brazilian traditional medicine, Ouratea species 
have been indicated for the treatment of palsy, erysipelas and 
uterine wounds (Barroso, 1986). Leaves of O. spectabilis are used 
as stomachic and vermifuge, as well as for the treatment of 
gastric distress (Braga, 1960). Leaf infusions of O. parviflora have 
long been prescribed for the treatment of inflammation-related 
diseases such as rheumatism, sprains and arthritic disorders 
(Carbonari et al., 2006), and further skin diseases (Corrêa, 1975; 
Paulo et al., 1986; Felício et al., 1995). O. castaneifolia is known 
in the Amazon region of Brazil as “farinha-seca”, “mangue-
do-mato” or “pau-de-serra” and its bark is used as a tonic and 
astringent and contains tannins (Le Cointe, 1934). Extracts 
from the leaves of O. sulcata, either alone or in combination 
with other plants, are used to treat upper respiratory tract 
infections, dysentery, diarrhoea and toothache (Bouquet, 1969; 
Pegnyemb et al., 2005). Juices of leaves or flowers of O. reticulata 
are also used as a remedy for toothache. The stems are used 
internally against dysentery and cough (J.P. Kofani, personal 
communication; Manga et al., 2001). Extracts of the leaves of O. 
elongata, O. sulcata and O. flava are used in cases of rheumatic 
and gastric distress (Gangoué-Piéboji et al. 2006; Mbing et al., 
2003a). On the other hand, the compounds responsible for 
exerting these activities have not been defined, due to a lack 
of studies on these species. 
Phytochemistry and chemotaxonomy
Different flavonoids such as flavones (1-10), flavonols (11-16), 
flavanonol (17), isoflavones (18-27), and flavan-3-ol (28-31), 
have been identified in several Ouratea species. Only three 
flavone aglycones were reported in this genus, apigenin (1) in 
O. parviflora (Araújo et al., 2011), and two methyl derivatives: 
5,4’-dihydroxy-3’,5’,7-trimethoxyflavone (2) (Nascimento et 
al., 2009), and 5,7,4’-trihydroxy-3’,5’-dimethoxyflavone (3) 
(Suzart, 2007b) isolated from the leaves of O. castaneifolia and 
O. cuspidata, respectively.
Phytochemical investigations of the leaves and flower 
extracts of O. hexasperma, allowed the isolation of five 
C-glycosylflavones: 6-C-glucopyranosyl-luteolin (4), from leaves 
(Daniel et al., 2005), and swertisin (5), swertiajaponin (6), vitexin 
(7), and orientin (8) from inflorescence (Suzart et al., 2012). The 
vitexin derivative 6”-O-acetylvitexin (9) was isolated from the 
leaves of O. gilgiana (Njock et al., 2012), and 2’’-O-acetyl-7-O-
methyl vitexin (10), was obtained from the leaves of O. turnarea 
(Mbing et al., 2009). The phytochemical study of the stem 
extract from O. cuspidata led to the isolation of 3’-O-methyl-
quercetin (11), and its 3-E-O-D-galactopyranosyl derivative (12) 
(Suzart, 2007b). The gossypetin-3-O-E-galactopyranoside (13) 
and 8-hydroxy-quercetin derivate were obtained from leaves 
of O. parviflora (Felício et al., 2004). Rutin (14) (Suzart et al., 
2012), quercetin 3-O-glucoside (15) (Daniel et al., 2005), and 
two new prenylflavonoids (6-E-E-dimethylallylkaempferol-7-
O-E-glucoside (16), and 6-E-E-dimethylallylaromadendrin-7-
O-E-glucoside (17)) (Carvalho et al., 2008b) were obtained from 
flowers, leaves and branches of O. hexasperma, respectively. 
Isoflavones methoxy derivatives have been mainly found 
in the wood, stems and stem bark, and less frequently in the 
leaves and roots, of Ouratea species. From the stem extract of 
O. ferruginea, four methyl isoflavones derivatives were isolated: 
5,4’-dihydroxy-7,5’,3’-trimethoxy-isoflavone (18), 7,3’-di-O-
methylorobol (19), 5-hydroxy-7,3’4’5’-tetramethoxy-isoflavone 
(20), and piscigenin (21) (Fidelis et al., 2012); in contrast, only 
the 4’,5,7-trimethoxyisoflavone (22) (Moreira et al., 1994) 
was isolated from the roots of O. hexasperma, lanceolone 
(23), and 4’,5-dimethoxy-6,7-methylenedioxyisoflavone (24) 
was isolated from the leaves of O. turnarea (Mbing et al., 
2009). Two isoflavones, (24) and 3’-methoxyirilone (25), with 
a methylenedioxyl-group at C-6, C-7 of ring A were isolated 
from the stem bark of O. flava (Mbing et al., 2006). Velandia et 
al. reported the isolation of two new chlorinated isoflavones 
from the extract of stem and branches of O. semisserrata: the 
3’,6,8-trichloro-4’,5-dihydroxy-7-methoxyisoflavone (26) and 
3’,5’,6,8-tetrachloro-4’,5-dihydroxy-7-methoxyisoflavone 
(27) (Velandia et al., 1998b; 2002). Three flavan-3-ols, 
epicatechin (28) (Daniel et al., 2005; Fidelis et al., 2012), 
(-)-3,3’,5,5’,7-pentahydroxy-4’-methoxyepicatechol (29), 
catechin (30) (Monache et al., 1967c), and a cianidin (31) 
(Gartlan et al., 1980) were reported in several Ouratea species.
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The biflavonoids found in this genus are dimeric 
compounds of flavone-flavone (32-53); flavone-flavanone (54-
56); flavone-flavanonol (57); flavanonol-flavanonol (58-59); 
chalcone-chalcone (63-68); chalcone-flavone (66); and, rarely, 
biisoflavanones (60-62), as well as flavan-3-ol dimers (70-72) 
(see Chart 1). Biflavonoids from Ouratea genus can be used 
as chemical markers because they can be used to determine 
differences among these taxa according to the linkage 
between the flavonoid units. The biflavones, amentoflavone 
(32, C-3’oC-8”), agathisflavone (42, C-6oC-8”), and its methyl 
ether derivatives (33-46), were reported mainly in the leaves 
of several Ouratea species. These bioflavonoids are the 
most indicated as chemotaxonomic markers of this genus. 
However, other dimers have occasionally been found, such 
as 4’’’-O-methyl-robustaflavone (47, C-3’oC-6”), which was 
reported from the leaves of O. semisserrata (Bosso, 2003), and 
(C-6oC-6”)-bigenkwanin (48), isolated together with 45, from 
the leaves of O. spectabilis (Felício et al., 1995).
Biflavonoids containing an oxygen linking the unities such 
as those known as Ochnaflavone (C-3’-OoC-4’”)(53) (Zintchem 
et al., 2007), lanaraflavone (C-4’-OoC-8”)(49) and its two methyl 
ether (50-51), were isolated from the leaves of O. semisserrata, 
and 52 was isolated from the leaves of O. hexasperma (Velandia 
et al., 2002; Daniel et al., 2005). The Ochnaflavone (53) is rarely 
found in Ouratea; it was isolated only from O. staudtii (Zintchem 
et al., 2007).
Other dimers (C-6oC-8”) of the flavone-flavanone type: 
zenkeriane A (54), zenkeriane B (55), and rhusflavone (56) 
were obtained from the leaves of O. zenkeri (Mbing et al., 
2009), as well as a new flavanonol dimer, 3-hydroxy-4’,5,7-
trimethoxyflavone-(C-6oC-8”)-3”-hydroxy-3”’,4”’,5”,7”-
tetramethoxyflavone (59), which was isolated from the leaves 
of O. multiflora (Felício et al., 2001). Sulcatone A (57), a flavone-
flavanonol, and 3-hydroxy-2,3-dihydroapigenyl-(C-4’’’-OoC-3’)-
dihydrokaempferol (58), a flavanone-flavanonol, were isolated 
from leaves of O. sulcata (Pegnyemb et al., 2005).
The roots of O. hexasperma, collected in the Amazonian 
cerrado, yielded three biisoflavanones, hexaspermone A (60), 
B (61) and C (62), which were reported for the first time in the 
literature (Moreira et al., 1994).
Chalcone dimers are found in several Ouratea species, 
mainly in African species. Lophirone A (63) and lophirone G 
(64) were obtained from the leaves from Ouratea species (see 
Chart 1). The occurrence of biflavonoids in the stem bark 
and root is less frequent, but chalcone dimers of complex 
structure, including flavumone A (65), calodenin B (66) and C 
(70), isolated from O. flava; lophirone C (67) and isolophirone 
C (68), obtained from O. turnarea; and the chalcone-flavone 
dimer, named flavumone B (66), also isolated from O. flava 
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(Mbing et al., 2003a; Zintchem et al., 2008), are rarely found in 
Brazilian species.
Two epimers, proantocianidin A (71)  and B (72), 
were isolated from the root of Ouratea sp. (Monache 
et al.,1967a,b; 1970). Compounds 70-72 were the only 
proantocyanidin dimers obtained from Ouratea genus. 
A flavanol dimer isolated from Ouratea sp. showed anti-
tumoral activity against sarcoma-180 and Walker 256 in vivo 
(Oliveira et al., 1972). The triterpenes are usually present in leaves, branches, 
flowers and stems of Ouratea species, while none were 
reported from roots (see Chart 2). The triterpenes D-amyrin 
(73), E-amyrin (74), lupeol (75) and friedelin (78) are found 
more frequently. A new triterpene, lup-15,20(29)-dien-
3E,28-diol (83), besides 75, was isolated from the ethanol 
extract of leaves of O. multiflora (Felício et al., 2001a). 
Three diterpenes were isolated in the two Ouratea species: 
16D-hydroxykaurane (84) and 16D-hydroxykaurane-19-oic 
acid (85) from O. parviflora (Felício et al., 2004), and 16D,17-
dihydroxykauran-19-oic acid (86) from O. semisserrata 
(Velandia et al., 1998a). Sitosterol (87), stigmasterol (88) 
and campesterol (89) can be recovered as a mixture, 
and 3-O-E-glycopyranosylsitosterol (90 )  and 3-O-E-
glycopyranosylstigmasterol (91) were yielded as a mixture 
in several species of Ouratea genus. Other steroids, such as 
7-oxostigmat-5-en-3E-ol (92) and 7-oxostigmasta-5,22-dien-
3E-ol (93), have only been obtained from O. semisserrata 
(Velandia et al., 2002).
Several other constituents were isolated from Ouratea 
species. Some of these compounds such as lignin (94-95), 
norisoprenoid (96), dihydrobenzofuranones (105-106), depside 
(107), and indole alkaloid (108), as well as carbohydrates, 
benzoic and cinnamic acid derivates and a mixture of fat acid 
esters have been found less frequently in this genus (Estevam 
et al., 2006; Rosa, 1939a,b). Chart 3 shows constituents 94-137.
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No. Compounds Plant Part Reference
1 apigenin O. parviflora Leaves Araújo et al., 2011
2
5,4’-dihydroxy-3’,5’,7-
trimethoxyflavone
O. castaneifolia Stem Nascimento et al., 2009
3
5,74’-trihydroxy-3’,5’-
dimethoxyflavone
O. cuspidata Leaves Suzart, 2007b
4 6-C-glucopyranosyl-luteolin O. hexasperma Leaves Daniel et al, 2005
5 swertisin O. hexasperma Flower Suzart et al., 2012
6 swertiajaponin O. hexasperma Flower Suzart et al., 2012
7 vitexin O. hexasperma Flower Suzart et al., 2012
8 orientin O. hexasperma Flower Suzart et al., 2012
9 6”-O-acetylvitexin O. gilgiana Leaves Njock et al., 2012
10 2”-O-acetyl-7-O-methylvitexin O. turnarea Leaves Mbing et al., 2009
11 3’-O-methyl-quercetin O. cuspidata Stem Suzart, 2007b
12
5,7,4’-trihydroxy-3’-methoxy-3-
E-O-D-galactopyranosylflavone O. cuspidata Stem Suzart, 2007b
13
gossypetin-3-O-E-
galactopyranoside
O. parviflora Leaves Felicio et al., 2004
14 rutin O. hexasperma Flower Suzart et al., 2012
15 quercetin-3-O-glucoside O. hexasperma Leaves Daniel et al, 2005
16
6-E-E-dimethylallylkaempferol-
7-O-E-glucoside O. hexasperma Branches Carvalho et al., 2008b
17
6-E-E-
dimethylallylaromadendrin-7-
O-E-glucoside
O. hexasperma Branches Carvalho et al., 2008b
18
5,4’-dihydroxy-7,5’,3’-
trimethoxy-isoflavone
O. ferruginea Stem Fidelis et al., 2012
19 7,3’-di-O-methylorobol O. ferruginea Stem Fidelis et al., 2012
20
5-hydroxy-7,3’4’5’-
tetramethoxy-isoflavone
O. ferruginea Stem Fidelis et al., 2012
21 piscigenin O. ferruginea Stem Fidelis et al., 2012
22 4’,5,7-trimethoxyisoflavone O. hexasperma Root Moreira et al., 1994
23 lanceolone O. turnarea Leaves Mbing et al., 2009
24
4’,5-dimethoxy-6,7-
methylenedioxyisoflavone
O. turnarea Leaves Mbing et al., 2009
O. flava Stem bark Mbing et al., 2006
25 3’-methoxyirilone O. flava Stem bark Mbing et al., 2006
26
3’,6,8-trichloro-4’,5-dihydroxy-
7-methoxyisoflavone
O. semisserrata Wood Velandia et al., 1998b
O. semisserrata Branches Velandia et al., 2002
27
3’,5’,6,8-tetrachloro- 
-4’,5-dihydroxy-7-
methoxyisoflavone
O. semisserrata Wood Velandia et al., 1998b
O. semisserrata Branches Velandia et al., 2002
Chart 1. 
Flavonoids (1-31) and biflavonoids (32-72) from Ouratea species.
(cont.)
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28 epicatechin O. ferruginea Leaves Fidelis et al., 2012
O. hexasperma Leaves Daniel et al., 2005
29
(-)-3,3',5,5',7-pentahydroxy-4'-
methoxyepicatechol
O. sp. Root Monache et al., 1967
30 catechin O. sp. Root Monache et al., 1967
31 cianidin O. affins - Gartlan et al., 1980
O. calantha - Gartlan et al., 1980
32 amentoflavone O. aquatica Leaves Lima et al., 2006
O. castaneifolia Leaves Nascimento et al., 2009
O. cuspidata Leaves Suzart et al;., 2007b
O. elongata Leaves Bikobo et al., 2009
O. ferruginea Leaves Fidelis et al., 2012
O. gilgiana Leaves Njock et al., 2012
O. microdonta Leaves Carvalho et al., 2008a
O. multiflora Leaves Felício et al., 2001a
O. parviflora Leaves Araújo et al., 2011
O. semisserrata Leaves Velandia et al., 2002
O. staudtii Leaves Zintchem et al., 2007
O. sulcata Leaves Pegnyemb et al., 2005
O. turnarea Root Zintchem et al., 2008
O. zenkeri Leaves Mbing et al., 2009
33 bilobentin O. elongata Leaves Bikobo et al., 2009
O. staudtii Leaves Zintchem et al., 2007
34 sequoieflavone O. ferruginea Leaves Fidelis et al., 2012
O. elongata Leaves Bikobo et al., 2009
35 podocarpusflavone A O. elongata Leaves Bikobo et al., 2009
O. multiflora Leaves Carbonezi et al., 2007
O. semisserrata Leaves Velandia et al., 2002
O. semisserrata Branches Velandia et al., 2002
O. staudtii Leaves Zintchem et al., 2007
36
7,7”-di-O-
methylamenthoflavone
O. castaneifolia Leaves Nascimento et al., 2009
37
7”,4’”-di-O-
methylamenthoflavone-
O. multiflora Leaves Carbonezi et al., 2007
38 7,4’-di-O-metilamentoflavone O. semisserrata Leaves Bosso, 2003
39 putraflavone O. cuspidata Leaves Suzart, 2007b
40 heveaflavone O. castaneifolia Leaves Nascimento et al., 2009
O. multiflora Leaves Carbonezi et al., 2007
41
4’,4”’,7,7”-tetra-O-
methylamenthoflavone
O. castaneifolia Leaves Nascimento et al., 2009
42 agathisflavone O. gilgiana Leaves Njock et al., 2012
Chart 1. cont.
(cont.)
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O. hexasperma Leaves Daniel et al., 2005
O. microdonta Leaves Carvalho et al., 2008a
O. nigroviolacea Leaves Mbing et al., 2006
O. parviflora Leaves Araújo et al., 2011
O. staudtii Leaves Zintchem et al., 2007
O. sulcata Leaves Pegnyemb et al., 2005
43 7”-O-methylagathisflavone O. hexasperma Leaves Daniel et al., 2005
O. microdonta Leaves Carvalho et al., 2008a
O. parviflora Leaves Araújo et al., 2011
44 ouratine B O. nigroviolacea Leaves Mbing et al., 2006
45 7,7”-di-O-methylagathisflavone O. spectabilis Leaves Felício et al., 1995
O. parviflora Leaves Felício et al., 2004
46 ouratine A O. nigroviolacea Leaves Mbing et al., 2006
47 4’’’-O-methylrobustaflavone O. semisserrata Leaves Bosso, 2003
48 (6o6”)-bigenkwanin O. spectabilis Leaves Felício et al., 1995
49 lanaraflavone O. semisserrata Leaves Velandia et al., 2002
50 7-O-methyllanaraflavone O. semisserrata Leaves Velandia et al., 2002
51 7,4’”-di-O-methyllanaraflavone O. semisserrata Leaves Velandia et al., 2002
52 7,7”-di-O-methyllanaraflavone O. hexasperma Leaves Daniel et al., 2005
53 ochnaflavone O. staudtii Leaves Zintchem et al., 2007
54 zenkeriane A O. zenkeri Leaves Mbing et al., 2009
55 zenkeriane B O. zenkeri Leaves Mbing et al., 2009
56 rhusflavone O. zenkeri Leaves Mbing et al., 2009
57 sulcatone A O. sulcata Leaves Pegnyemb et al., 2005
58
3-hydroxy-2,3-
dihydroapigenyl-(C-4’-OoC-3’)-
dihydrokaempferol
O. sulcata Leaves Pegnyemb et al., 2005
59
3-hydroxy-4’,5,7-
trimethoxyflavone-(C-6-OoC-
8”)-3”-hydroxy-3”’,4”’,5”,7”-
tetramethoxyflavone
O. multiflora Leaves Carbonezi et al., 2007
60 hexasperma A O. hexasperma Root Moreira et al., 1994
61 hexasperma B O. hexasperma Root Moreira et al., 1994
62 hexasperma C O. hexasperma Root Moreira et al., 1994
63 lophirone A O. elongata Leaves Bikobo et al., 2009
O. flava Leaves Mbing et al., 2003b
O. flava Stem bark Mbing et al., 2003a
O. staudtii Leaves Zintchem et al., 2007
O. sulcata Leaves Pegnyemb et al., 2005
O. turnarea Leaves Mbing et al., 2009
O. zenkeri Leaves Mbing et al., 2009
Chart 1. cont.
(cont.)
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64 lophirone G O. flava Leaves Mbing et al., 2003b
65 flavumone A O. flava Stem bark Mbing et al., 2003a
66 calodenin B O. flava Stem bark Mbing et al., 2003a
O. turnarea Root Zintchem et al., 2008
67 lophirone C O. turnarea Root Zintchem et al., 2008
68 isolophirone C O. turnarea Root Zintchem et al., 2008
69 flavumone B O. flava Stem bark Mbing et al., 2003a
70 calodenin C O. flava Stem bark Mbing et al., 2003a
71 proantocianidin A O. sp. Root Oliveira et al., 1972
72 proantocianidin B O. sp. Root Oliveira et al., 1972
Chart 2. 
Terpenoids (73-86) and steroids (87-93) from Ouratea species
No. Compounds Plant Part Reference
73 D-amirin O. castaneifolia Leaves Nascimento et al., 2009
O. cuspidata Leaves Suzart et al., 2007a
O. microdonta Leaves Carvalho et al., 2008a
74 E-amirin O. castaneifolia Leaves Nascimento et al., 2009
O. cuspidata Leaves Suzart et al., 2007a
O. microdonta Leaves Carvalho et al., 2008a
O. nitida Leaves Estevam et al., 2006
75 lupeol O. castaneifolia Leaves Nascimento et al., 2009
O. cuspidata Leaves Suzart et al., 2007a
O. flava Leaves Mbing et al., 2003b
O. floribunda Wood Carvalho et al., 2000
O. hexasperma Branches Carvalho et al., 2008b
O. microdonta Leaves Carvalho et al., 2008a
O. semiserrata Leaves Velandia et al., 2002
76 taraxerol O. castaneifolia Leaves Nascimento et al., 2009
O. castaneifolia Stem Nascimento et al., 2009
77 germanicol O. castaneifolia Leaves Nascimento et al., 2009
78 friedelin O. castaneifolia Stem Nascimento et al., 2009
O. ferruginea Leaves Fidelis et al., 2012
O. floribunda Wood Carvalho et al., 2000
O. nitida Leaves Estevam et al., 2006
O. parviflora Leaves Araújo et al., 2012
O. semiserrata Leaves Velandia et al., 2002
79 3-E-friedelinol O. castaneifolia Stem Nascimento et al., 2009
O. ferruginea Leaves Fidelis et al., 2012
Chart 1. cont.
(cont.)
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O. floribunda Wood Carvalho et al., 2000
80 lupeone O. ferruginea Leaves Fidelis et al., 2012
O. flava Leaves Mbing et al., 2003b
81
3-E-O-acyl-olean-12-en-28-oic 
acid
O. hexasperma Flower Suzart et al., 2012
82 3,4-seco-friedelan-3-oic acid O. nitida Leaves Estevam et al., 2006
83 lup-15,20(29)-dien-3E,28-diol O. multiflora Leaves Felício et al., 2001b
84 16D-hydroxykaurane O. parviflora Leaves Felício et al., 2004
85 16D-hydroxykaurane-19-oic O. parviflora Leaves Felício et al., 2004
86
16D,17-dihydroxykauran-19-oic 
acid
O. semiserrata Leaves Velandia et al., 1998a
87 sitosterol O. castaneifolia Leaves Nascimento et al., 2009
O. ferruginea Leaves Fidelis et al., 2012
O. hexasperma Branches Carvalho et al., 2008b
O. hexasperma Flower Suzart et al., 2012
O. microdonta Leaves Carvalho et al., 2008a
O. parviflora Leaves Araújo et al., 2012
O. semiserrata Leaves Velandia et al., 2002
O. semiserrata Branches Velandia et al., 2002
88 stigmasterol O. castaneifolia Leaves Nascimento et al., 2009
O. ferruginea Leaves Fidelis et al., 2012
O. hexasperma Branches Carvalho et al., 2008b
O. hexasperma Flower Suzart et al., 2012
O. microdonta Leaves Carvalho et al., 2008a
O. nigroviolacea Leaves Mbing et al., 2006
O. parviflora Leaves Felício et al., 2004
O. semiserrata Leaves Velandia et al., 2002
O. semiserrata Branches Velandia et al., 2002
O. sulcata Leaves Pegnyemb et al., 2005
89 campesterol O. ferruginea Leaves Fidelis et al., 2012
O. hexasperma Branches Carvalho et al., 2008b
O. parviflora Leaves Araújo et al., 2012
90 3-O-E-glycopyranosylsitosterol O. ferruginea Leaves Fidelis et al., 2012
O. gilgiana Leave Njock et al., 2012
O. hexasperma Branches Carvalho et al., 2008b
O. hexasperma Flower Suzart et al., 2012
91
3-O-E-
glycopyranosylstigmasterol
O. ferruginea Leaves Fidelis et al., 2012
O. sulcata Leaves Pegnyemb et al., 2005
Chart 2. cont.
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No. Compounds Plant Part Reference
92 7-oxostigmat-5-en-3E-ol O. semiserrata Branches Velandia et al., 2002
93 7-oxostigmata-5,22-dien-3E-ol O. semiserrata Branches Velandia et al., 2002
94 eudesmin O. semisserrata Branches Velandia et al., 2002
95 epieudesmin O. semisserrata Branches Velandia et al., 2002
96
6,9-dihydroxymegastigma-4,7-
dien-3-one
O. parviflora Leaves Araújo et al., 2012
O. semisserrata Leaves Velandia et al., 2002
97 tocopherol O. parviflora Leaves Araújo et al., 2012
O. semisserrata Leaves Velandia et al., 2002
98
1E-O-(4-hydroxybenzoyl)-E-D-
glucopyranoside
O. semisserrata Leaves Velandia et al., 2002
99
1E-O-(4-hydroxyphenyl)-6-
O-(4-methoxycinamoyl)-D-
glucopyranoside
O. semisserrata Leaves Velandia et al., 2002
100
1E-O-(4-hydroxyphenyl)-
6-O-(4-hydroxybenzoyl)-D-
glucopyranoside
O. parviflora Leaves Felício et al., 2004
O. semisserrata Leaves Velandia et al., 2002
101 D-D-glucopyranose O. semisserrata Leaves Velandia et al., 2002
102 E-D-glucopyranose O. semisserrata Leaves Velandia et al., 2002
103 methyl-E-D-glycopyranoside O. cuspidata Stem Suzart et al., 2007a
104 methyl myoinositol O. hexasperma Leaves Moreira et al., 1999
105 aquilegiolide O. reticulata Root bark Manga et al., 2001
106 menisdaurilide O. reticulata Root bark Manga et al., 2001
107 atranorin O. floribunda Wood Carvalho et al., 2000
108 serotobenine O. gilgiana Leaves Njock et al., 2012
O. turnarea Root Zintchem et al., 2008
109 syringic acid O. gilgiana Leaves Njock et al., 2012
O. ferruginea Leaves Fidelis et al., 2012
110 syringic aldehyde O. ferruginea Stem Fidelis et al., 2012
111 2,6-dimethoxyhydroquinone O. ferruginea Stem Fidelis et al., 2012
112 ferulic aldehyde O. ferruginea Stem Fidelis et al., 2012
113 vanillic acid O. ferruginea Stem Fidelis et al., 2012
114
1-hydroxy-2-methoxy-4-(1E-3-
hydroxy-1-propenyl)-benzene 
O. ferruginea Stem Fidelis et al., 2012
115
3,5-dimethoxy-4-
hydroxydihydrocinamaldehyde
O. ferruginea Stem Fidelis et al., 2012
116 2,6-dimethoxybenzoquinone O. ferruginea Stem Fidelis et al., 2012
117
4-methoxy-2,5-dihydroxy-
benzoic acid
O. microdonta Leaves Carvalho et al., 2008a
118
p-hydroxybenzoic acid ethyl 
ester
O. nitida Leaves Estevam et al., 2006
119 detracosan O. nitida Leaves Estevam et al., 2006
120
6,10,14-trimethyl-2-
pentadecanone
O. nitida Leaves Estevam et al., 2006
121 methyl ester of lauric acid O. nitida Leaves Estevam et al., 2006
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Biological activities
The crude extracts as well as pure compounds obtained from 
Ouratea species possess a number of biological activities that 
have been reported from time to time.
Antiviral activity
Viral infections remain a major threat to humans and animals 
and there is a crucial need for new antiviral agents, especially 
with the development of resistant viruses (Bagla et al., 2012). 
Extracts from the leaves from Ouratea lucens were evaluated for 
antiviral activity as well as for their cytotoxic effects against 
herpes virus 1 (HSV-1) and (HSV-2) 2, poliovirus, vesicular 
stomatitis virus (VSV), and parainfluenza-3 virus. Good antiviral 
activities of ethanol and aqueous extracts were observed 
against HSV-1 and HSV-2, while petroleum ether extract 
showed similar activities only on HSV-1, as determined by a 
VR assay. The dichloromethane extract showed slight activities 
against HSV-1 and HSV-2. Similar results were observed in 
the DPI assay. The ethanol extract displayed a higher activity 
against VSV, as the aqueous extract was more active against 
HSV-1, both with an ED50 at 9 μg/ml. For Para 3 virus infections, 
aqueous extracts were most active, with an ED50 at 20 μg/ml, 
while ethanol extract had the best activity against Polio-1 with 
an ED50 at 30 μg/ml. The used concentrations of extracts do not 
have cytotoxic effects (Roming et al., 1992).
The ethanol extracts of Ouratea castaneifolia, O. semiserrata 
and O. spectabilis displayed activity against human herpes 
virus type 1 (HSV-1), vaccinia virus (VACV) and murine 
encephalomyocarditis virus (EMCV), assayed by MTT, against 
positive controls (acyclovir/Calbiochem and D-2a interferon/
Bergamo). Leaves extracts from Ouratea spectabilis showed 
activity against HSV-1, with EC50 values lower than 50 μg/ml, 
while leaves extracts from O. castaneifolia and O. semiserrata 
were moderately active, with EC50 values ranging from 56.5 
122 ethyl ester of lauric acid O. nitida Leaves Estevam et al., 2006
123 methyl ester of myristic acid O. nitida Leaves Estevam et al., 2006
124 ethyl Ester of myristic acid O. nitida Leaves Estevam et al., 2006
125 methyl ester of palmitic acid O. nitida Leaves Estevam et al., 2006
126 ethyl ester of palmitic acid O. nitida Leaves Estevam et al., 2006
127 methyl ester of stearic acid O. nitida Leaves Estevam et al., 2006
128 ethyl ester of stearic acid O. nitida Leaves Estevam et al., 2006
129 methyl ester of pentadecanoic
130 methyl ester of heptadecanoic
131 methyl ester of beenic
132 methyl ester of lignoceric
133 n-butyl stearate
134 methyl ester of oleic acid O. nitida Leaves Estevam et al., 2006
135 ethyl ester of oleic acid O. nitida Leaves Estevam et al., 2006
136 methyl ester of arachidonic O. nitida Leaves Estevam et al., 2006
137 ethyl ester of linoleic acid O. nitida Leaves Estevam et al., 2006
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to 97.24 μg/ml, respectively. Moderate to low activity against 
EMCV, was observed for extracts from Ouratea castaneaefolia 
(EC50 185.9 μg/ml) and O. semiserrata (EC50 465.7 μg/ml). 
The extracts from Ouratea spectabilis, O. castaneifolia and O. 
semiserrata inhibited the replication of VACV-WR, a DNA-virus, 
with EC50 values below 50 μg/ml. Among the active extracts, 
the one from O. semiserrata should be highlighted due to the 
EC50 at 7.4 μg/ml (Brandão et al., 2011).
Agathisflavone (42), 7”-methyl-agathisflavone (43) and lupeol 
(75), obtained from O. parviflora, were assayed for antiviral 
activities against HSV-1 with 50% ED (ED50) values of 11.2, 25.8 
and 47.5 μg/ml, respectively. Regarding anti-HSV-2 activity, 
42 and 43 presented ED50 values of 2.8 and 1.5, respectively, 
whereas 75 did not show anti-HSV-2 activity (Araújo et al., 2011).
Anti-tumour and anticancer activity
Cancer is responsible for high rates of human mortality. Many 
chemotherapeutics currently used in cancer therapy are tumour 
growth inhibiting agents  that hinder DNA replication and 
transcription (Sharma, 2013).
A flavanol dimer isolated from Ouratea sp., was assayed for 
anti-tumour activity against Sarcoma 180 in mice and Walker 
256 in rats. The proantocianidin (71-72), whose absolute 
configuration was not mentioned by the authors, showed 
significant anti-tumour activity. Doses of 300 mg/kg/day, i.p. 
for five days decreased tumour growth by 50-70% (Oliveira 
et al., 1972).
The cytotoxic and anti-tumour activities against murine 
tumours were evaluated in vivo for 43, 32, and 32a, by MTT 
assays. 7’’-O-methyl-agathisflavone (43) induced significant 
growth delay against Sarcoma 180 (S180) cells, with IC50 values 
of DNA and protein synthesis at 3 and 6.8 μM, respectively, as 
well as anti-tumour activity against an ascitic S180 tumour at 
a dose of 80 mg/kg (% T/C 140), in which 5-fluorouracil, used 
as a positive control, at a dose of 38 mg/kg (% T/C 140) showed 
equal values (Grynberg et al., 1994).
DNA topoisomerases are a class of enzymes involved in 
the regulation of DNA supercoiling, crucial for the replication 
and transcription of DNA. Consequently, these enzymes are 
targets for chemotherapeutic intervention in antibacterial 
and anticancer therapies (Ishar et al., 2006). In 2002, Grynberg 
et al. reported the effect of the biflavonoids 7’’-O-methyl-
agathisflavone (43), isolated from Ouratea hexasperma, 
amentoflavone (32) obtained from O. semiserrata, and the 
acetyl derivative of 32 (32a) on Ehrlich ascitic carcinoma cells, 
human K562 leukemic cell line and action on the human DNA 
topoisomerases I and II-D. All compounds were shown to be 
inhibitors of human DNA topoisomerases I at 200 μM, and 
only 7’’-O-methyl-agathisflavone (43) at 200 μM inhibited DNA 
topoisomerases II-D. The biflavonoids showed concentration-
dependent growth inhibitory activities on Ehrlich carcinoma 
cells in a 45-h culture, assayed by a tetrazolium method, 
with IC50 24 μM for I, 26 μM for II and 10 μM for IID. These 
biflavonoids were assayed on human K562 cell line in 45-h 
culture, but only 7’’-O-methyl-agathisflavone (43) showed 
42% growth inhibitory activity at 90 μM. Posteriorly, cytotoxic 
and anti-tumour activities against murine tumours were 
evaluated in vivo for 43, 32, and 32a, by the MTT assays. 
7’’-O-methyl-agathisflavone (43) showed significant growth 
delay against Sarcoma 180 (S180) cells, with IC50 values of 
DNA and protein synthesis at 3 and 6.8 μM, resp., as well as 
anti tumour activity against an ascitic S180 tumour at a dose 
of 80 mg/kg (% T/C 140), in which 5-fluorouracil, used as a 
positive control, at a dose of 38 mg/kg (% T/C 140) showed 
equal values.
B i f lavonoids  7 ,7 ’ ’ -d imethyl lanaraf lavone  (52 ) , 
agathisflavone (42) and 7’’-methylagathisflavone (43) isolated 
from the leaves of O. hexasperma, as well as a mixture of 52 
and 43, were assayed against HT-29 colon adenocarcinoma, 
NCI-H460 non-small cell lung carcinoma, MCF-7 breast 
cancer cell, OVCAR-3 ovarian adenocarcinoma cells, and 
RXF-393 renal cell carcinoma, using etoposide as a reference 
compound. Compound 52 promoted growth inhibitory activity 
at 3-5 μg/ml (< 25% control growth) in NCI-H460, MCF-7, and 
OVCAR-3 cell lines; this effect was also confirmed by the low 
values of IC50 for these cell lines (0.77-2.5 μg/ml). However, 
for HT-29 and RXF-393 cell lines, this compound induced a 
comparatively low cytotoxic effect. Compound 43 showed the 
highest activity, with an IC50 value of around 4 μg/ml for all 
five of the cell lines tested. A mixture of 52 and 43 showed 
growth inhibition activity (< 25% of control cell growth) among 
the cell lines tested at 18-20 μg/ml, with IC50 values ranging 
from 8-10 μg/ml. Compound 42 did not have any significant 
effect on cell growth in any of the cell lines tested (Daniel 
et al., 2007).
B i f l a v o n o i d s  h e v e a f l a v o n e  ( 4 0 ) ,  7 ’ ’ , 4 ’ ’ ’ - d i - O -
methylamentoflavone (37), podocarpusflavone-A (35), and 
amentoflavone (32), obtained from leaves of Ouratea multiflora, 
were assayed for cytotoxicity toward mouse lymphoma (L5178) 
and a melanoma cancer cell line (KB). None of the compounds 
were active against this cell line (Carbonezi et al. 2007).
Anti-inflammatory activity
Reactive oxygen species (ROS) are intimately involved in 
the pathogenesis of inflammatory processes and they can 
exacerbate tissue damage. In addition to the protective effects 
of the endogenous antioxidant defence system, natural products 
with antioxidant activity are also important to attenuate 
oxidative damage, complementing those defences (Carbonari 
et al., 2006). The antioxidant potential of crude extracts 
(CEOP) and fractions (OP4) from leaves of O. parviflora revealed 
anti-inflammatory effects in vitro through the scavenging 
of radicals 2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH), 
hydroxyl radical (HOr, by deoxyribose method), superoxide 
anion (O2rm, according to Robak & Gryglewski, 2002), and 
lipid peroxidation (by TBA method) in rat liver homogenate. 
The CEOP and OP4 showed strong inhibitory activity to lipid 
peroxidation induced by tert-butyl peroxide (IC50 2.3 and 
1.9 mg/ml, respectively), and concentration-dependent 
inhibition of deoxyribose oxidation (14.9 and 0.2 μg/ml, 
respectively), as well as considerable antioxidant activity against 
O2rm(87.3 and 73.1 μg/ml, respectively) and DPPH radicals 
(55.4 and 38.3 μg/ml, respectively) (Carbonari et al., 2006).
Lipoxygenases constitute a family of non-haem iron 
containing dioxygenases widely distributed in animals and 
plants. It has been found that these lipoxygenase products play 
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a vital role in a variety of disorders such as bronchial asthma, 
inflammation and tumour angiogenesis (Zargar et al., 2013). The 
leaves and stem extracts from O. semisserrata showed 29.2 and 
7.8% 5-lipoxygenase inhibition, respectively. The in vitro assay 
of inhibition of 5-lipoxygenase constitutes a good model for the 
screening of plants with antiasthma activity (Braga et al. 2000).
Hepatoprotective activity on carbon tetrachloride-induced 
hepatoctye injury
Carbon tetrachloride (CCl4) attacks hepatocytes, causing 
damage to plasma membranes by lipid peroxidation. The 
cytosolic enzymes in the injured hepatocytes leak through 
the cell due to cell permeability. Aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) enzymes are 
involved in the hepatoprotective activity. The crude extract 
(CEOP) and hydro-alcoholic fraction (OP4) of O. parviflora 
were considered to be responsible of the hepatoprotective 
activity on CCl4-induced damage in rat hepatocytes. The pre-
treatment with CEOP and OP4 (300 mg/kg, for seven days) 
prevented lipid peroxidation, DNA damage and aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) 
release without affecting hepatic GSH content in CCl4-treated 
animals (Carbonari et al., 2006). CCl4 significantly increased (by 
90%) levels of lipid hydroperoxides, carbonyl protein content 
(64%), DNA damage index (133%), AST (261%), ALT (212%), and 
catalase activity (23%), and also caused a decrease of 60% in 
GSH content (Carbonari et al., 2006).
Enzyme inhibition activity
For a long time, the biological activities of plant polyphenols 
over plants, as well as in humans, have arguably been attributed 
to their capacity to exert antioxidant actions and/or to their 
propensity to form precipitating complexes with proteins in a 
rather nonspecific manner (Haslam, 1996; Quideau et al., 2011). 
Today, there is compelling evidence that strongly suggests 
that the mechanisms by which plant polyphenols exert their 
protective actions against cardiovascular and neurodegenerative 
diseases, as well as cancer and diabetes, are not simply due to 
their redox properties, but rather to their ability to directly bind 
to target proteins (or peptides) (Quideau et al., 2011).
Aldose reductase is responsible by catalysing the reduction 
of glucose to sorbitol in the polyol pathway. Excess sorbitol 
has been linked to a number of ocular diabetic complications 
including keratopathy, cataract, and retinopathy (Kador, 1988; 
Sugiyama et al. 2000). Administration of aldose reductase 
inhibitors at the onset of diabetes or galactosaemia has been 
shown to prevent these complications (Sugiyama et al. 2000). 
7,7”-di-O-methylagathisflavone (45) and 6,6”-bigenkwanin 
(48), isolated from the EtOH extract of O. spectabilis, exhibited 
inhibitory activities against aldose reductase. The compounds 
concentrations studied required to produce 50% inhibition 
of the enzyme-catalysed reaction (45, IC50 27.7 μM and 48, 
IC50 11.9 μM) were good in comparison with quercetin (IC50 
31.4 μM), which was used as a control (Felício et al., 1995). 
The inhibitory activity against bovine lens aldose reductase 
shown by 45 and 48 represents a potential therapeutic interest 
in diabetes pathology. Posteriorly, the cytotoxicity of 48, 45 
and 48a (derivative obtained by methylation of compound 
48) was evaluated in SIRC cell line by spectrophotometric 
measurement. The 48, 45 and 48a presented IC50 of 381.9 ± 
22.29; 426.74 ± 22.05 and 359.7 ± 24.25 mg/ml respectively. 
These compounds present significant inhibitory activity for 
aldose reductase of SIRC cell (Simoni et al., 2002).
Inhibition of acetylcholinesterase by drugs raises the levels 
of acetylcholine and, thus, offers a symptomatic treatment 
for Alzheimer’s disease (Darvesh et al., 2013). Compounds 
heveaflavone (40), 7cc,4ccc-di-O-methylamentoflavone (37), 
podocarpusflavone-A (35), and amentoflavone (32) were 
submitted to preliminary TLC screening to select potential 
acetylcholinesterase inhibitors, in which none inhibited the 
enzyme at concentrations of 0.1 and 1.0 μM (Carbonezi et al., 
2007).
Xenobiotic metabolism (phase I and II) enzymes are 
widely known for their role in the metabolism of drugs and 
other foreign compounds. The reactive metabolites may 
undergo additional metabolism by phase I or II enzymes to 
inactive products. Therefore, the induction of either phase 
I or II enzymes can result in an increased detoxification of 
carcinogens (Moon et al., 2006). The effect of Ouratea ferruginea, 
flavonoids 18, 19, 21 and 34, toward in vitro GST (phase II 
enzyme) and ECOD (phase I enzyme) activity was evaluated. 
Piscigenin (21) and 5,4c-dihydroxy-7,3c,5c-trimethoxyisoflavone 
(18) showed the best inhibitory effects, inhibiting almost 70% 
and 75% of GST activity, respectively. The inhibitory effect of 
7,3c-di-O-methylorobol (19) on GST activity was not observed. 
GSTs are promising therapeutic targets because specific 
isozymes are overexpressed in a wide variety of tumours. 
The study also revealed that the compounds inhibited ECOD 
activity in vitro. Sequoiaflavone (34) was the most potent 
inhibitor, inhibiting ECOD assay by 75.2% in comparison to 
the control. Isoflavones 18, 19 and 21 inhibited ECOD activity 
by 33.1, 22.2 and 56.5%, respectively (Fidelis et al., 2012).
Vasodilator activity
The World Health Organisation estimates that hypertension 
affects approximately 25% of adults worldwide (Lawes 
et al., 2008). Hypertension is associated with severe 
complications, including end organ damage, arteriosclerosis, 
left ventricular (LV) hypertrophy and stroke (Kannel, 2000); 
it is imperative that additional treatments that also prevent 
cardiovascular complications are developed (Dolinsky et 
al., 2013).
The vasodi lator  ef fects  of  O.  semiserrata  s tem 
hydroethanolic extract (OSE) and its EtAcO fraction (OSR) 
were evaluated with endothelium-intact aortic rings. 
The OSR produced more potent vasodilation (IC50 3.5 μg/
ml) than OSE (IC50 > 30 μg/ml). The OSR also presented a 
higher content of total proanthocyanidins (21.8 ± 1.5%) in 
comparison to OSE (6.5 ± 0.4%), thus leading the authors to 
suggest that compounds of this class play an important role 
in the vasorelaxation. The investigation of the vasodilatation 
mechanism of OSR revealed that its vasorelaxing effect 
was completely abolished by L-NAME (300 μM), a nitric 
oxide (NO) synthase inhibitor, but not by a muscarinic 
antagonist (atropine, 1 μM) nor by a cyclooxygenase inhibitor 
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(indomethacin, 10 μM). These findings showed that OSR, a 
proanthocyanidin-rich fraction of O. semiserrata, induces 
vasodilatation by a mechanism dependent on endothelium-
derived factors, likely NO (Cortes et al., 2002). Posteriorly, 
leaves and stem hydroethanolic extracts from O. castaneifolia, 
O. semisserrata and O. spectabilis were assayed in aortic 
rings of rats pre-contracted with phenylephrine. Among 
these, only stem hydroethanolic extract from O. semiserrata 
produced significant vasodilating activity (63 ± 3%, n = 6), at 
100 mg/ml (Valadares et al. 2003).
Antimalarial activity
Malaria is an infectious disease, of parasitic origin, that is a 
major cause of global morbidity and mortality. It is believed 
that about 300-500 million individuals contract the disease 
annually and more than 1 million people die of malaria every 
year (Murray et al., 2012). Plasmodium, the causative agent of 
malaria, is dependent on completing a complex cycle inside 
its vector,  Anopheles mosquito, in order to be transmitted 
(Ghosh et al., 2000). However, the emergence and rapid spread 
of insecticide resistant mosquitoes and of drug-resistant 
Plasmodium parasites, combined with the lack of an effective 
vaccine, severely undermine current control efforts (Trape et 
al., 2011). Clearly, the available means to ﬁght the disease are 
insufﬁcient (Wang et al., 2013).
Estevam et al. (2005) reported the preliminary evaluation 
of in vivo antimalarial activity of the n-hexane, chloroform, 
ethyl acetate and hydromethanol extracts from the leaves 
of Ouratea nitida Aubl. using mice (Mus musculus) infected 
with Plasmodium berghei, NK-65 strains. Among them, only 
the hexane extract showed good activity against Plasmodium 
berghei of 47.87%, 77.95% and 51.04%, at tested doses of 250, 500 
and 1000 mg/kg, respectively. Test results showed significant 
in vivo antimalarial activity, compared to the positive control 
chloroquine phosphate, whose activity against P. berghei was 
100%. In contrast, increasing the concentration from 500 to 
1000 mg/kg gave unsatisfactory results. The chromatographic 
purification of the hexane extract led to isolation of friedelin, 
E-amirin, 3,4-seco-friedelan-3-oic acid and tetracosan 
compounds.
Antimicrobial activity
Crude extracts from plants used in folk medicine have been 
screened in vitro by many research groups for antibacterial 
properties. The antibacterial activity of flavonoids is 
increasingly documented (Cushnie and Lamb, 2005).
Compounds sulcatone A (57) and 3-hydroxy-2,3-
dihydroapigenyl-[C-4’-OoC-3’]-dihydrokaempferol (58), 
obtained from the aerial parts of O. sulcata, displayed activity 
against Staphylococcus aureus (MIC value of 12.50 μg/ml at 57 
and 8.12 μg/ml at 58) and Bacillus subtilis (MIC value of 8.51μg/
ml at 57 and 10.05 μg/ml at 58), Gram positive bacterium. These 
activities were almost equivalent to those demonstrated by 
streptomycin sulphate (MIC value of 6.25μg/ml at 57 and 
0.85 μg/ml at 58). However, none of these compounds were 
active against Vibrio anguillarium (Gram positive bacterium) 
or Escherichia coli (Gram negative bacterium) in agar diffusion 
assays (Pegnyemb et al., 2005). Biflavones heveaflavone, 
7’’,4’’’-dimethylamentoflavone, podocarpusflavone-A and 
amentoflavone, obtained from leaves of O. multiflora, showed 
weak activity against the Gram-positive bacteria Staphylococcus 
aureus and Bacillus subtilis at the 10 μg/ml concentration, and 
only compounds heveaflavone and podocarpusflavone-A 
inhibited the growth of S. aureus at a concentration of 0.5 μg/
ml. The compounds tested showed moderate inhibition (zone 
inhibition = 7.0-10.0 mm), compared to streptomycin sulphate 
(zone inhibition = 30-35 mm), used as  the reference antibiotic, 
at 5 μg/ml (Carbonezi et al., 2007).
Ouratea extracts display moderate or no inhibition against 
several species of Gram-positive cocci bacteria (Staphylococcus 
aureus, S. epidermidis, S. saprophyticus, Enterococcus sp., En. 
hirae,), Gram-negative bacilli (Escherichia coli, Klebsiella 
pneumonia, Serratia marsescens, Pseudomonas aeruginosa and 
Acinetobacter baumannii) or fungi (Candida spp., Cryptococcus 
neoformans sero D, Aspergillus spp., Tricophyton spp.) in disk 
diffusion assays and with a final concentration between 2 and 
1024 μg/ml. The methanolic extracts from leaves of O. sulcata 
showed activity against Staphylococcus spp., with inhibition 
zones of 10-13 mm, whereas similar extracts from O. flava and 
O. elongata only showed activity against Candida albicans, with 
inhibition zones of 7-13 and 7-10 mm, respectively (Gangoué-
Piéboji et al., 2006). The crude CH2Cl2:MeOH (1:1) extract from 
roots of O. turnarea showed only moderate activity against 
Gram-positive cocci. The minimal inhibitory concentration of 
these crude extracts varied from 2.5 to 5 mg/ml. Serotobenine, 
isolated from crude extract of O. turnarea, was evaluated by 
the same antimicrobial assay and did not exhibit any activity 
for any bacterial strains tested (Zintchem et al., 2008). The 
antimicrobial activities of crude MeOH extracts of O. zenkeri 
and O. turnerae leaves were also examined by Mbing et al. (2009) 
and both extracts exhibited moderate antimicrobial activity 
against these microorganisms.
Recently, Bikobo et al. (2009) evaluated and compared 
the antimicrobial properties of methanol extracts of Ouratea 
sulcata, O. flava, O. elongata, O. reticulata and O. staudtii. Again, 
it was observed that the activity of Ouratea extracts was more 
pronounced against Gram-positive bacteria and yeast than 
Gram-negative bacteria, for which no activity was observed. 
The most active antimicrobial plants were O. sulcata and O. 
flava. Some biflavonoids evaluated were also most active 
against gram positive compared to gram negative bacteria. 
Aflatoxins are secondary metabolites of Aspergillus flavus 
and A. parasiticus, been shown to be toxigenic, carcinogenic, 
mutagenic, and teratogenic to different animal species 
(Fan and Chen, 1999). The biflavonoids 6,6”-bigenkwanin 
(48); tetramethoxybigenkwanin (48a); amenthoflavone (32), 
and 7,7”-di-O-methylagathisflavone (45) obtained from 
O. spectabilis, O. multiflora and O. parviflora have shown 
an inhibitory effect on the aflatoxin biosynthesis that are 
secondary metabolites of Aspergillus flavus. A. flavus used as 
a control produced 188.6 μg/ml of AFB1 and 12.58 μg/ml of 
AFB2, while the fungus treated with biflavonoids 48, 48a, 32 
and 45 at 5 μg/ml concentration produced 56.58, 42.65, 37.42 
and 45.19 μg/ml of AFB1, and 2.38, 2.87, 1.88 and 3.17 μg/ml of 
AFB2, respectively. At a concentration of 10 μg/ml, the results 
obtained were 22.58, 22.29, 18.41 and 27.56 μg/ml of AFB1 and 
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2.34, 0.75, 1.11 and 1.55 μg/ml of AFB2 for compounds 48, 48a, 
32 and 45, respectively. The cytotoxicity of (45), (48) and (48a) 
was also evaluated for SIRC cell line by spectrophotometric 
measurements, to determine the concentrations of substances 
that inhibited the absorbance to 50% of the control level (IC50). 
Compounds 45, 48 and 48a presented IC50 of 426.74 ± 22.05, 
381.9 ± 22.29 and 359.7 ± 24.25 mg/ml respectively (Gonçalez 
et al., 2001).
Antioxidant activities
The antioxidant activities of biflavones 32, 35, 37 and 40 from 
O. multiflora were tested toward DPPH radicals. Compound 32 
showed moderate scavenging activity (IC50 18.5 μg/ml) in this 
test, while 35, 37 and 40 showed weak scavenging activity, 
which confirms the dependence of the antioxidant activity on 
the number of free phenol groups of the tested compounds 
(Carbonezi et al., 2007).
Discussion
The Ouratea genus has been characterised to be a good source 
of flavonoids and biflavonoids and some species are used in 
folk medicine, mainly for the treatment of inflammatory and 
infectious diseases. It has been established that leaves extracts 
of O. parviflora are important to attenuate the oxidative damage 
caused by ROS (Carbonari et al., 2006) and O. semisserrata has 
shown lipoxygenase inhibiting potential (Braga et al., 2000); 
thus these extracts can be considered as phytotherapeutics for 
the treatment of inflammation. These results have contributed 
for confirmation of the anti-inflammatory effects of Ouratea 
species in the traditional medicine. For example, leaves 
extracts of O. elongata, O. sulcata, O. flava and O. parviflora 
are used in the treatment of diseases such as rheumatism, 
sprains, arthritic disorders and toothache (Carbonari et al., 
2006; Bouquet, 1969; Pegnyemb et al., 2005; Gangoué-Piéboji 
et al. 2006; Mbing et al., 2003a).
The use of plants from this genus in respiratory tract 
infections, dysentery, diarrhoea, erysipelas and uterine 
wounds can be justified because of the antimicrobial and 
antiviral effects of the extracts or phytochemicals. Although 
some flavonoids and extracts of Ouratea have been shown to 
be more active against Gram-positive bacteria than Gram-
negative bacteria (Bikobo et al. 2009), other flavonoids, such 
as catechins, also appear to have greater activity against Gram-
positive than Gram-negative bacteria. Ikigai and colleagues 
(Ikigai et al., 1993) have demonstrated that epigallocatechin 
gallate induced the leakage of small molecules from the 
intraliposomal space of liposomes (used as model bacterial 
membranes). Ikigai et al. suggested that the low catechin 
susceptibility of Gram-negative bacteria may be, at least 
partially, attributable to the presence of lipopolysaccharides 
in the membrane bilayer acting as a barrier (Ikigai et al., 1993; 
Cushnie et al., 2005). It is believed that, as for the catechins, the 
flavonoids tested are less susceptible to Gram-negative bacteria 
due to the presence of the membrane bilayer. No study of the 
antibacterial mechanism of action of the Ouratea ﬂavonoids 
has been published to date. However, these compounds still 
have important roles in traditional medicine. Furthermore, 
flavonoids or extracts containing flavonoids, when used along 
with conventional antibiotics against quite resistant bacterial 
strains, exert a significant synergistic effect, as described in 
the literature (Stepanovic et al., 2003).
Notable antiviral (against HSV, Parainfluenza-3 and 
Poliomyelitis-1) and antifungal (inhibitory effect on the 
aflatoxin biosynthesis in the Aspergillus flavus and A. 
parasiticus) activities were observed for biflavonoids and 
extracts from Ouratea species (Roming et al., 1992; Gonçalez 
et al., 2001). Biflavonoids from plants of the Ouratea genus are 
good candidates for research into the mechanisms of antiviral 
action; additional studies are needed as they may help in the 
development of antiviral therapy.
Several relevant activities have been described for Ouratea 
species that are not related to the traditional uses, such 
as anticancer (Oliveira et al., 1972; Daniel et al., 2007) and 
chemopreventive (Fidelis et al., 2012), antimalarial (Estevam 
et al. 2005), hepatoprotective (Carbonari et al., 2006) and 
vasorelaxant or anti-hypertensive activities (Valadares et al. 
2003).
It remains surprising that despite the potent vasorelaxant 
effect found for extracts of O. semisserrata, any traditional 
uses were related to treat hypertensive diseases. Thus, 
additional studies would be necessary for the development of 
phytotherapeutics obtained from Ouratea extracts, such as O. 
semisserrata and O. hexasperma.
Other activities requiring attention are those that involve 
the inhibition of enzymes by flavonoids. Good results were 
found for aldose reductase inhibition using biflavonoids 
from O. spectabilis (Felício et al., 1995). Biflavones of O. 
hexasperma showed high inhibition of DNA-topoisomerase I 
and II (Grynberg et al., 2002). It is possible, therefore, that the 
mechanisms of action involved in the antiviral and anticancer 
activities can be related to the vital enzymatic inhibition of 
cellular metabolism.
There is strong evidence in the literature that has led us 
to believe that biflavonoids from Ouratea, as well as several 
polyphenols of plants, have the ability to modulate target 
enzymes (Quideau et al., 2011). Thus, these compounds may 
exert their protective actions against several diseases.
Conclusion
The genus Ouratea presents large chemical diversity, comprising 
mainly flavonoids and biflavonoids. The more abundant 
biflavonoids, such as amentoflavone and agathisflavone, have 
been considered chemotaxonomic markers of this genus. Of 
300 species, only 25 have been examined. It was perceived that 
extensive research work had been done with some species 
of this genus; however, a large number of species are still 
chemically and/or pharmacologically unknown. While this 
review has attempted to unite the relevant information for 
these species, the bioactive profile of Ouratea species and its 
flavonoids as the main bioactive compound, clearly suggests 
future research priorities. Convincing ethnopharmacological 
evidence is presented alluding to the use of leaves from 
Ouratea species for rheumatism, sprains, arthritic disorders 
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and toothaches, but there has been no research regarding this 
information. The anti-inflammatory activity remains poorly 
explored, both in vivo and in vitro; however, the results found 
were promising. Flavonoids are well known for their biological 
properties and although a suite of compounds belonging to 
this class of phytochemicals, such as biflavonoids, has been 
isolated from the Ouratea genus, only a few have been subjected 
to pharmacological assays. Several studies have revealed the 
potential of these plants and their constituents for anticancer, 
antimalarial, antiviral, antimicrobial and vasodilating 
activities. In our opinion, the presence of biologically active 
biflavonoids makes the species of the Ouratea genus extremely 
promising, considering specially that the time of action of 
dimers ais longer than that of monomers, as cited by Iwu M.M. 
(1986) concering the biflavanones of Garcinia. Moreover, these 
compounds can be used as models to attain more potent and 
effective synthetic derivatives. Taken together, all of the results 
compiled here indicate that the genus may play an important 
role in the discovery of new medicinal agents.
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